Page last updated: 2024-09-03

cgp 361a and cp 93129

cgp 361a has been researched along with cp 93129 in 1 studies

Compound Research Comparison

Studies
(cgp 361a)
Trials
(cgp 361a)
Recent Studies (post-2010)
(cgp 361a)
Studies
(cp 93129)
Trials
(cp 93129)
Recent Studies (post-2010) (cp 93129)
2133109011

Protein Interaction Comparison

ProteinTaxonomycgp 361a (IC50)cp 93129 (IC50)
5-hydroxytryptamine receptor 1ARattus norvegicus (Norway rat)3
5-hydroxytryptamine receptor 1DHomo sapiens (human)2.2
5-hydroxytryptamine receptor 2CHomo sapiens (human)6.4
5-hydroxytryptamine receptor 1BRattus norvegicus (Norway rat)0.015

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Atack, J; Chadha, A; Duty, S; Sur, C1

Other Studies

1 other study(ies) available for cgp 361a and cp 93129

ArticleYear
The 5HT(1B) receptor agonist, CP-93129, inhibits [(3)H]-GABA release from rat globus pallidus slices and reverses akinesia following intrapallidal injection in the reserpine-treated rat.
    British journal of pharmacology, 2000, Volume: 130, Issue:8

    Topics: Animals; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Globus Pallidus; In Vitro Techniques; Male; Movement Disorders; Propanolamines; Pyridines; Pyrroles; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Reserpine; Serotonin Antagonists; Serotonin Receptor Agonists; Tritium

2000